T. Nagata

发表

Association between the catechol‐O‐methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese population

K. Tagai, Shunichiro Shinagawa, Hisashi Yamada, 2015, International journal of geriatric psychiatry.

Effectiveness of carbamazepine for benzodiazepine‐resistant impulsive aggression in a patient with frontal infarctions

K. Nakayama, Daisuke Harada, K. Aoki, 2007, Psychiatry and clinical neurosciences.

Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation

K. Tagai, Shunichiro Shinagawa, K. Nakayama, 2018, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients

M. Shigeta, Shunichiro Shinagawa, K. Kondo, 2022, Journal of personalized medicine.

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease

M. Shigeta, Shunichiro Shinagawa, T. Nagata, 2022, Journal of personalized medicine.

Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2014, Journal of Neural Transmission.

Genetic association between APOA1 and APOD polymorphisms and Alzheimer’s disease in a Japanese population

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2013, Journal of Neural Transmission.

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease

Hisashi Yamada, Kazuhiro Kondo, Tohru Ohnuma, 2015, Dementia and Geriatric Cognitive Disorders Extra.

Erratum to: Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population

K. Tagai, Shunichiro Shinagawa, Hisashi Yamada, 2015, NeuroMolecular Medicine.

Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2015, NeuroMolecular Medicine.

Craniopharyngioma with high FDG uptake.

T. Kinoshita, H. Miyata, Fumiko Kinoshita, 2012, Clinical nuclear medicine.

Pharmacotherapeutic combinations for the treatment of Alzheimer’s disease

S. Nakajima, Masaru Mimura, Y. Noda, 2022, Expert opinion on pharmacotherapy.

A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom

M. Shigeta, Shunichiro Shinagawa, K. Kondo, 2021, Prion.

Mirtazapine improves visual hallucinations in Parkinson's disease: a case report

N. Tsuno, K. Tagai, Shunichiro Shinagawa, 2013, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease

M. Mimura, M. Shigeta, S. Nakajima, 2020, Scientific Reports.

Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case–control study

N. Hattori, Shunichiro Shinagawa, Hisashi Yamada, 2017, International journal of geriatric psychiatry.

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2016, PloS one.

DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer’s disease and amnesic mild cognitive impairment patients

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2016, Neuroscience Letters.

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2016, PloS one.

Differentiation between amnestic‐mild cognitive impairment and early‐stage Alzheimer's disease using the Frontal Assessment Battery test

Shunichiro Shinagawa, K. Nakayama, T. Nagata, 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Correlation between both Morphologic and Functional Changes and Anxiety in Alzheimer's Disease

Kiyotaka Nemoto, N. Tsuno, K. Tagai, 2014, Dementia and Geriatric Cognitive Disorders.

Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2013, Dementia and Geriatric Cognitive Disorders Extra.

Association between Neurotrophin-3 Polymorphisms and Executive Function in Japanese Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer Disease

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2012, Dementia and Geriatric Cognitive Disorders.

Association between BDNF Polymorphism (Val66Met) and Executive Function in Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer Disease

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2012, Dementia and Geriatric Cognitive Disorders.

Association between brain‐derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease

Shunichiro Shinagawa, H. Yamada, K. Nakayama, 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Association between executive dysfunction and hippocampal volume in Alzheimer's disease

Shunichiro Shinagawa, K. Nakayama, T. Nagata, 2010, International Psychogeriatrics.

Association between Nerve Growth Factor Gene Polymorphism and Executive Dysfunction in Japanese Patients with Early-Stage Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2012, Dementia and Geriatric Cognitive Disorders.

Education level is associated with neuropsychiatric symptoms in patients with amnestic‐mild cognitive impairment

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2022, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer’s disease

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2020, Aging & mental health.

Psychosocial or clinico‐demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE‐AD study

M. Mimura, A. Graff-Guerrero, S. Nakajima, 2017, International journal of geriatric psychiatry.

Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.

M. Mimura, S. Nakajima, Shunichiro Shinagawa, 2016, Journal of Alzheimer's disease : JAD.

Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.

Shunichiro Shinagawa, Hisashi Yamada, K. Nakayama, 2013, Biochemical and biophysical research communications.

Pharmacological management of behavioral disturbances in patients with Alzheimer’s disease

M. Mimura, S. Nakajima, Y. Noda, 2020, Expert opinion on pharmacotherapy.

Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder

K. Nakayama, T. Nagata, K. Ono, 2007, Psychiatry and clinical neurosciences.

A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease

K. Tagai, Shunichiro Shinagawa, K. Nakayama, 2012, International Psychogeriatrics.

The time‐dependent trajectory of neuropsychiatric symptoms in patients with Alzheimer's disease

M. Shigeta, Shunichiro Shinagawa, T. Nagata, 2020, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.

M. Mimura, M. Shigeta, S. Nakajima, 2018, Journal of Alzheimer's disease : JAD.

Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.

M. Mimura, A. Graff-Guerrero, S. Nakajima, 2017, Journal of Alzheimer's disease : JAD.

Anosognosia in patients with Alzheimer's disease: current perspectives

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2020, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Cognitive Dysfunction in Patients With Late-Life Somatic Symptom Disorder: A Comparison According to Disease Severity.

K. Tagai, Shunichiro Shinagawa, K. Nakayama, 2015, Psychosomatics.

Pharmacotherapy for Alzheimer’s disease: a perspective on treatment strategies in Japan

M. Mimura, S. Nakajima, Y. Noda, 2018, Expert opinion on pharmacotherapy.

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study.

M. Mimura, M. Shigeta, S. Nakajima, 2020, The Journal of clinical psychiatry.

Executive Dysfunction Correlated With 2-Year Treatment Response in Patients With Late-Life Undifferentiated Somatoform Disorders.

K. Tagai, Shunichiro Shinagawa, K. Nakayama, 2016, Psychosomatics.

Clinicodemographic and Psychosocial Factors Related to Presentation or Severity of Delusions of Theft among Females with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2020, Clinical gerontologist.

Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease

Shunichiro Shinagawa, K. Ishii, K. Nakayama, 2009, Psychiatry and clinical neurosciences.

Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer's disease

Shunichiro Shinagawa, K. Nakayama, T. Nagata, 2009, International Psychogeriatrics.

Effects of neuropsychiatric symptoms of dementia on reductions in activities of daily living in patients with Alzheimer's disease

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2020, Geriatrics & gerontology international.

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population

N. Hattori, Shunichiro Shinagawa, Hisashi Yamada, 2016, Dementia and Geriatric Cognitive Disorders Extra.

Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementia with in a Japanese population

Shunichiro Shinagawa, H. Arai, K. Nakayama, 2018 .

Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer's disease

Shunichiro Shinagawa, K. Nakayama, T. Nagata, 2009, International Psychogeriatrics.

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2013, Dementia and Geriatric Cognitive Disorders Extra.

Blood DNA Methylation Levels in the WNT5A Gene Promoter Region: A Potential Biomarker for Agitation in Subjects with Dementia.

M. Shigeta, K. Tagai, Shunichiro Shinagawa, 2021, Journal of Alzheimer's disease : JAD.